Ausdal Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$387K Buy
1,837
+210
+13% +$42.1K 0.02% 731
2026
Q2
$310K Buy
1,627
+258
+19% +$44.3K 0.01% 814
2026
Q1
$231K Buy
1,369
+122
+10% +$20.9K 0.01% 882
2025
Q4
$210K Buy
+1,247
New +$203K 0.01% 879
2023
Q4
– Sell
-35,271
Closed -$4.31M – 462
2023
Q3
$4.31M Buy
+35,271
New +$4.49M 0.59% 33
2018
Q4
– Sell
-2,043
Closed -$249K – 312
2018
Q3
$249K Buy
2,043
+47
+2% +$5.54K 0.07% 316
2018
Q2
$219K Buy
+1,996
New +$213K 0.07% 342
2018
Q1
– Sell
-2,099
Closed -$224K – 374
2017
Q4
$224K Buy
2,099
+29
+1% +$3.1K 0.08% 310
2017
Q3
$230K Buy
2,070
+87
+4% +$9.3K 0.09% 286
2017
Q2
$205K Buy
+1,983
New +$195K 0.09% 282
2017
Q1
– Sell
-2,613
Closed -$231K – 292
2016
Q4
$231K Buy
+2,613
New +$238K 0.11% 215
2016
Q1
– Sell
-1,071
Closed -$121K – 589
2015
Q4
$121K Buy
+1,071
New +$116K 0.06% 272

Other funds holding IBB

Ausdal Financial Partners's IBB Position: Q3 2026 in Review

Ausdal Financial Partners increased its iShares Biotechnology ETF (IBB) stake by 13% in Q3 2026, buying an estimated $42.1K and bringing the position to 1,837 shares worth $387K. The position accounts for 0.02% of the portfolio, ranked #731.

Ausdal Financial Partners first reported a position in IBB in Q4 2015 and has held it in 12 quarters since. The position peaked at $4.31M in Q3 2023. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Ausdal Financial Partners held 1,837 shares of iShares Biotechnology ETF worth $387K as of Q3 2026.
  • Ausdal Financial Partners bought 210 iShares Biotechnology ETF shares in Q3 2026, an estimated $42.1K.
  • iShares Biotechnology ETF made up 0.02% of Ausdal Financial Partners's portfolio in Q3 2026, its #731 holding.
  • Ausdal Financial Partners first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 12 quarters since.
  • Ausdal Financial Partners's iShares Biotechnology ETF position peaked at $4.31M in Q3 2023.
  • 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Ausdal Financial Partners's 13F filing for Q3 2026, filed 16 Nov 2026.